Drug company gives ofatumumab update
Drug company gives ofatumumab update
Biotech firm Genmab has announced an update on development plans for ofatumumab in autoimmune indications focusing on relapsing multiple sclerosis following the transfer of the rights to ofatumumab from GlaxoSmithKline (GSK) to Novartis at the end of 2015...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1386 Views
-
Last post by frodo
-
- 0 Replies
- 1030 Views
-
Last post by frodo
-
- 0 Replies
- 2659 Views
-
Last post by NHE
-
- 0 Replies
- 1326 Views
-
Last post by frodo
-
- 0 Replies
- 1307 Views
-
Last post by frodo
-
- 0 Replies
- 1282 Views
-
Last post by frodo
-
- 0 Replies
- 1682 Views
-
Last post by NHE
-
- 0 Replies
- 550 Views
-
Last post by NHE
-
- 1 Replies
- 3177 Views
-
Last post by Tif